Featured Topics
Calendar

February 25, 2026

FY/Q4 2025 Results / Annual Report

April 24, 2026

Annual Stockholders’ Meeting 2026
Press Releases
Share Price / Index
November 12, 2025
Business figures for the third quarter:
Bayer confirms 2025 Group outlook, progresses on strategic priorities
November 06, 2025
Dr. Judith Hartmann to become new Chief Financial Officer of Bayer AG
November 06, 2025
Not intended for U.S. and UK Media – Late-Breaking data from FINE-ONE Phase III study presented at ASN Kidney Week 2025
Finerenone showed statistically significant reduction of UACR in adults with chronic kidney disease associated with type 1 diabetes

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.